SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010072
Filing Date
2020-08-10
Accepted
2020-08-10 09:27:31
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20200630x10q.htm   iXBRL 10-Q 1088586
2 EX-31.1 zyne-20200630xex31d1.htm EX-31.1 11612
3 EX-31.2 zyne-20200630xex31d2.htm EX-31.2 11349
4 EX-32.1 zyne-20200630xex32d1.htm EX-32.1 6067
5 EX-32.2 zyne-20200630xex32d2.htm EX-32.2 6088
6 GRAPHIC zyne-20200630x10q001.jpg GRAPHIC 74913
  Complete submission text file 0001558370-20-010072.txt   5134105

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20200630.xsd EX-101.SCH 35557
8 EX-101.CAL zyne-20200630_cal.xml EX-101.CAL 41930
9 EX-101.DEF zyne-20200630_def.xml EX-101.DEF 132885
10 EX-101.LAB zyne-20200630_lab.xml EX-101.LAB 308852
11 EX-101.PRE zyne-20200630_pre.xml EX-101.PRE 263186
12 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20200630x10q_htm.xml XML 942626
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 201087522
SIC: 2834 Pharmaceutical Preparations